| Community Clinic | |
|
202 South 4th Street West Baker MT 59313-1119 | |
| (406) 778-2833 | |
| (406) 778-5155 |
| Full Name | Community Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 202 South 4th Street West, Baker, Montana |
| Authorized Official Name and Position | Selena R Nelson (CFO) |
| Authorized Official Contact | 4067785103 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Community Clinic Po Box 1119 202 South 4th Street West Baker MT 59313-1119 Ph: (406) 778-2833 | Community Clinic 202 South 4th Street West Baker MT 59313-1119 Ph: (406) 778-2833 |
| NPI Number | 1700895752 |
|---|---|
| Provider Enumeration Date | 08/07/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 0941119499 |
|---|---|
| Medicare Enrollment ID | O20051013000381 |
News Archive
Exercise can enhance the development of new brain cells in the adult brain, a process called adult neurogenesis. These newborn brain cells play an important role in learning and memory. A new study has determined that mice that spent time running on wheels not only developed twice the normal number of new neurons, but also showed an increased ability to distinguish new objects from familiar objects.
KHN hosts a discussion with former Democratic Sen. Tom Daschle and conservative health care analyst Avik Roy to explore the plans advanced by President Barack Obama and GOP presidential hopeful Mitt Romney. Romney focuses on some of those themes in a new ad incorporating video from this week's town hall debate.
Serena Auñón-Chancellor, M.D., M.P.H., Clinical Associate Professor of Medicine at LSU Health New Orleans School of Medicine's branch campus in Baton Rouge, is the lead author of a paper describing a previously unrecognized risk of spaceflight discovered during a study of astronauts involved in long-duration missions.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
With the current outbreak of swine flu, and in the absence of a vaccine or treatment at present, the only way to contain the virus is to get people around the world to take precautionary measures.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700895752 | NPI | - | NPPES |
| 720369 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Exercise can enhance the development of new brain cells in the adult brain, a process called adult neurogenesis. These newborn brain cells play an important role in learning and memory. A new study has determined that mice that spent time running on wheels not only developed twice the normal number of new neurons, but also showed an increased ability to distinguish new objects from familiar objects.
KHN hosts a discussion with former Democratic Sen. Tom Daschle and conservative health care analyst Avik Roy to explore the plans advanced by President Barack Obama and GOP presidential hopeful Mitt Romney. Romney focuses on some of those themes in a new ad incorporating video from this week's town hall debate.
Serena Auñón-Chancellor, M.D., M.P.H., Clinical Associate Professor of Medicine at LSU Health New Orleans School of Medicine's branch campus in Baton Rouge, is the lead author of a paper describing a previously unrecognized risk of spaceflight discovered during a study of astronauts involved in long-duration missions.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
With the current outbreak of swine flu, and in the absence of a vaccine or treatment at present, the only way to contain the virus is to get people around the world to take precautionary measures.
› Verified 3 days ago